Literature DB >> 18503262

New C5-alkylated indolobenzazepinones acting as inhibitors of tubulin polymerization: cytotoxic and antitumor activities.

Laurent Keller1, Stéphane Beaumont, Jian-Miao Liu, Sylviane Thoret, Jérôme S Bignon, Joanna Wdzieczak-Bakala, Philippe Dauban, Robert H Dodd.   

Abstract

A series of 5-alkylindolobenzazepin-7-ones was synthesized by Suzuki coupling between 3-iodoindole-2-carboxylates and the appropriate alpha-alkylbenzylamino o-boronic acids followed by cyclization to the lactam. Derivatives having a linear alkyl chain at C5 were found to be highly cytotoxic to KB cells with IC50 values in the 30-80 nM range. These compounds also inhibited the polymerization of tubulin with IC50's of 1-2 microM. Compound 4f (( S)-5-ethyl) showed comparable antiproliferative activities (IC50's of 30-70 nM) in a variety of cancer cell lines, cell growth being arrested at the G2/M phase. Compound 4f induced apoptosis in a dose-dependent manner in three different cancer cell lines and was shown to affect cell morphology in a manner consistent with its inhibitory action on tubulin polymerization. Using the experimental model of glioma grafted on the chick chorio-allantoic membrane, local treatment with compound 4f markedly reduced tumor progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18503262     DOI: 10.1021/jm701466p

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

Review 1.  An overview of tubulin inhibitors that interact with the colchicine binding site.

Authors:  Yan Lu; Jianjun Chen; Min Xiao; Wei Li; Duane D Miller
Journal:  Pharm Res       Date:  2012-07-20       Impact factor: 4.200

2.  Rigid Analogues of Antimitotic Indolobenzazepinones: New Insights into Tubulin Binding via Molecular Modeling.

Authors:  Valérie Pons; Stéphane Beaumont; Marie Elise Tran Huu Dau; Bogdan I Iorga; Robert H Dodd
Journal:  ACS Med Chem Lett       Date:  2011-06-05       Impact factor: 4.345

3.  Design and synthesis of novel antileishmanial compounds.

Authors:  Melanie Loedige
Journal:  Int J Med Chem       Date:  2015-01-21

4.  Inhibition of Microtubule Dynamics in Cancer Cells by Indole-Modified Latonduine Derivatives and Their Metal Complexes.

Authors:  Christopher Wittmann; Anastasiia S Sivchenko; Felix Bacher; Kelvin K H Tong; Navjot Guru; Thomas Wilson; Junior Gonzales; Hartmut Rauch; Susanne Kossatz; Thomas Reiner; Maria V Babak; Vladimir B Arion
Journal:  Inorg Chem       Date:  2022-01-07       Impact factor: 5.165

5.  Asymmetric synthesis of dibenzo[b,d]azepines by Cu-catalyzed reductive or borylative cyclization.

Authors:  Patricia Rodríguez-Salamanca; Rocío Martín-de la Calle; Verónica Rodríguez; Pedro Merino; Rosario Fernández; José M Lassaletta; Valentín Hornillos
Journal:  Chem Sci       Date:  2021-11-10       Impact factor: 9.825

6.  Elucidation of Structure-Activity Relationships in Indolobenzazepine-Derived Ligands and Their Copper(II) Complexes: the Role of Key Structural Components and Insight into the Mechanism of Action.

Authors:  Irina Kuznetcova; Felix Bacher; Samah Mutasim Alfadul; Max Jing Rui Tham; Wee Han Ang; Maria V Babak; Peter Rapta; Vladimir B Arion
Journal:  Inorg Chem       Date:  2022-06-17       Impact factor: 5.436

7.  Highly Antiproliferative Latonduine and Indolo[2,3-c]quinoline Derivatives: Complex Formation with Copper(II) Markedly Changes the Kinase Inhibitory Profile.

Authors:  Christopher Wittmann; Felix Bacher; Eva A Enyedy; Orsolya Dömötör; Gabriella Spengler; Christian Madejski; Jóhannes Reynisson; Vladimir B Arion
Journal:  J Med Chem       Date:  2022-02-01       Impact factor: 7.446

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.